FDA advertising "censorship" hearing canceled by House oversight subcommittee.
This article was originally published in The Tan Sheet
Executive Summary
FDA INFORMATION DISSEMINATION OVERSIGHT HEARING CANCELED by House Commerce/oversight subcommittee Chairman Barton (R-Tex.). Originally slated to be held Nov. 29 to address FDA advertising "censorship," the hearing has not been rescheduled.